First experience with chronic platelet GPIIb/IIIa receptor blockade: A pilot study of xemlofiban an orally active antagonist in unstable angina patients eligible for PTCA
Authors:
- Conrad SimpfendorferCSConrad Simpfendorfer
- Kandice Kottke-MarchantKKKandice Kottke-Marchant
- Eric J. TopolETEric J. Topol